Evaluating the effect of convalescent plasma (CP) on some cytokine storm indices in severe
COVID-19 patients. Totally, 62 patients were randomly assigned into two groups for this …

Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …

Since SARS-CoV-2 infection is rapidly spreading all around the world, affecting many
people and exhausting health care resources, therapeutic options must be quickly …

Introduction Passive antibody therapy has been used to immunize vulnerable people
against infectious agents. In this study, we aim to investigate the efficacy of convalescent …

Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …

Background The efficacy of convalescent plasma (CP) for the treatment of coronavirus
disease 2019 (COVID-19) remains unclear. Methods In a matched cohort analysis of …

Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life
of several hundred thousand worldwide. However, so far no approved vaccine or drug …

Abstract Introduction South America is one of the regions most affected by the COVID‐19
pandemic. Specific and affordable treatments are needed to treat SARS‐CoV‐2 infection …

Background Convalescent plasma (CP) is being used as a treatment option in hospitalized
patients with COVID-19. Till date, there is conflicting evidence on efficacy of CP in reducing …

Objectives The potential benefit of convalescent plasma (CP) therapy for coronavirus
disease 2019 (COVID-19) is highest when administered early after symptom onset. Our …